Anti-ABCC9 antibody [N319A/14] - C-terminal
Be the first to review this product! Submit a review
|
(6 Publications)
Mouse Monoclonal ABCC9 antibody. C-terminal. Suitable for WB, IHC-P and reacts with Rat, Human, Mouse samples. Cited in 6 publications. Immunogen corresponding to Recombinant Fragment Protein within Mouse Abcc9 aa 1500 to C-terminus.
View Alternative Names
SUR2, ABCC9, ATP-binding cassette sub-family C member 9, Sulfonylurea receptor 2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ABCC9 antibody [N319A/14] - C-terminal (AB174629)
4% formaldehyde-fixed SK-N-BE cells labeling ABCC9 using ab174629 at 1/100 dilution in ICC/IF. Cells were fixed for 15 minutes at room temperature and incubated with primary antibody for 1 hour at room temperature. Secondary antibody was a goat anti-mouse ATTO 488 (green) at 1/100 dilution incubated for 1 hour at room temperature. Counter stained with Phalloidin Texas Red F-actin stain. Nuclei were stained with DAPI (blue).
- WB
Supplier Data
Western blot - Anti-ABCC9 antibody [N319A/14] - C-terminal (AB174629)
All lanes:
Western blot - Anti-ABCC9 antibody [N319A/14] - C-terminal (ab174629) at 1/1000 dilution
All lanes:
Rat brain membrane lysate at 10 µg
Secondary
All lanes:
Goat anti-mouse IgG at 1/200 dilution
Predicted band size: 174 kDa
false
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ABCC9 plays an important role in the response to metabolic changes by linking cellular excitability to metabolism. As a component of the KATP channel complex it regulates the channel's open and closing states in response to intracellular ATP levels. This regulation impacts muscle contraction and insulin release significant processes in energy maintenance and homeostasis.
Pathways
ABCC9 is integrated into significant signaling networks such as the insulin secretion pathway and the cardiac muscle contraction pathway. It interacts with proteins like Kir6.2 a potassium channel protein forming the pore of KATP channels. These pathways illustrate ABCC9's involvement in glucose homeostasis and cardiac rhythm regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in medicine 12:1656718 PubMed41020224
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38791311
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 14:1115543 PubMed37180726
2023
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Renal physiology 324:F168-F178 PubMed36454699
2022
Applications
Unspecified application
Species
Unspecified reactive species
Acta pharmacologica Sinica 43:1349-1359 PubMed34697419
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 7:315 PubMed27721792
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com